Envoy Medical, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 0.225 million compared to USD 0.316 million a year ago. Net loss was USD 20.8 million compared to USD 29.92 million a year ago. Basic loss per share from continuing operations was USD 1.49 compared to USD 2.54 a year ago. Diluted loss per share from continuing operations was USD 1.49 compared to USD 2.54 a year ago. Envoy Medical, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 0.225 million compared to USD 0.316 million a year ago. Net loss was USD 20.8 million compared to USD 29.92 million a year ago. Basic loss per share from continuing operations was USD 1.49 compared to USD 2.54 a year ago. Diluted loss per share from continuing operations was USD 1.49 compared to USD 2.54 a year ago.
Envoy Medical is a Minnesota-based medical device company that designs, manufactures and distributes hearing aids and implants for people with hearing loss condition.